钙通道阻滞剂与牙龈增生的病例对照研究
本研究纳入131名参与者,其中91名服用钙通道阻滞剂(CCB)治疗高血压的患者,评估药物性牙龈增生(DIGE)及其相关因素,并分析唾液和龈沟液生物标志物。DIGE患者龈沟液中VEGF、EGF和MMP-8水平升高,唾液MMP-8在各组间有显著差异。结论提示炎症过程、组织损伤通路及生长因子可能参与DIGE发生。
要点
- DIGE患者龈沟液VEGF、EGF和MMP-8水平显著升高。
- 唾液MMP-8在组间差异显著,可能作为潜在生物标志物。
核心结论
- CCB可导致牙龈增生,缺乏牙间清洁和II型糖尿病是风险因素。
- DIGE可能涉及炎症过程、组织损伤通路及VEGF等生长因子的影响。
研究设计与样本
- 病例对照研究,共纳入131名参与者,其中91名服用CCB治疗高血压。
- DIGE患者按性别和种族与CCB非DIGE、无CCB无DIGE及牙周健康者进行组匹配。
- 采用基于微珠的多重免疫分析法评估生物标志物panel。
主要发现
- 缺乏每日牙间清洁和自我报告的II型糖尿病与DIGE诊断相关。
- 在CCB患者中,DIGE组龈沟液VEGF(p=0.032)、EGF(p=0.030)和MMP-8(p=0.008)水平较高。
- 唾液标志物中仅MMP-8在各组间有统计学显著差异(p<0.001)。
临床怎么用
- 对服用CCB的高血压患者,应评估牙龈增生并关注牙间清洁习惯和糖尿病史。
- 龈沟液VEGF、EGF、MMP-8及唾液MMP-8可能有助于识别DIGE相关炎症过程。
局限性
- 结果需在独立人群中验证,潜在致病机制需深入研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: As reported by the existing literature, calcium-channel blockers (CCB) can lead to gingival enlargement. The aims of this study were to investigate the factors associated with gingival enlargement in patients on CCB and to assess the saliva and gingival crevicular fluid (GCF) profile of patients on CCB with gingival enlargement. METHODS: A total of 131 participants were included. Data were collected from 91 patients taking CCB for treatment of systemic hypertension. The presence of drug-induced gingival enlargement (DIGE) was assessed clinically and associated with patient factors. Patients with DIGE were group-matched for gender and ethnicity with an equal number of consecutive CCB non-DIGE patients (control 1), no-CCB no-DIGE (control 2) and periodontally healthy with no DIGE (control 3) for the saliva and GCF analysis. A bead-based multiplex immunoassay was used to assess a panel of biomarkers. RESULTS: Twenty-two percent of patients on CCB were diagnosed with DIGE. Lack of daily interdental cleaning and self-reported diagnosis of type II diabetes were associated with the diagnosis of DIGE. When analysing patients only on CCB, those with DIGE had higher GCF levels of vascular endolthelial growth factor (VEGF) (p = 0.032), epidermal growth factor (EGF) (p = 0.030) and matrix metalloproteinase-8 (MMP-8) (p = 0.008). Among the salivary markers, only MMP-8 showed a statistically significant difference across groups (p < 0.001). CONCLUSIONS: This is the first study investigating saliva and GCF biomarkers in patients with DIGE and different control groups, suggesting that causes of the overgrowth might involve inflammatory processes, tissue damage pathways, and potentially an impact on growth factors like VEGF. Future research should verify these results in independent populations and explore the underlying pathogenic mechanisms in-depth. CLINICAL SIGNIFICANCE: Calcium-channel blockers (CCB) can lead to gingival enlargement. This study confirms lack of interdental cleaning and type II diabetes as risk factors. Elevated levels of VEGF, EGF, and MMP-8 in gingival crevicular fluid and MMP-8 in saliva suggest inflammatory processes and growth factors might play roles in this condition.
引用
- Mainas G, Santamaria P, Zoheir N, et al. Association between calcium-channel blockers and gingival enlargement: A case-control study. J Dent. 2024. PMID: 39159743. doi:10.1016/j.jdent.2024.105315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。